In vivo gene therapy of Parkinson's Disease

Details for Australian Patent Application No. 2004283053 (hide)

Owner NsGene A/S

Inventors Rosenblad, Carl; Tornoe, Jens; Wahlberg, Lars

Agent Cullen & Co

Pub. Number AU-A-2004283053

PCT Pub. Number WO2005/039643

Priority 60/512,918 22.10.03 US; PA 2003 01543 20.10.03 DK

Filing date 20 October 2004

Wipo publication date 6 May 2005

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/039643 Priority application(s): WO2005/039643

19 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283055-Combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity and lipase inhibitors

2004283047-Pharmaceutical composition comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker